| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.66B | 7.40B | 7.38B | 7.80B | 8.58B | 7.99B |
| Gross Profit | 2.32B | 3.11B | 2.85B | 3.39B | 4.15B | 3.98B |
| EBITDA | 513.11M | 645.26M | 503.39M | 529.50M | 1.26B | 1.50B |
| Net Income | 180.81M | 235.97M | 174.39M | 216.53M | 763.79M | 1.00B |
Balance Sheet | ||||||
| Total Assets | 10.50B | 9.66B | 10.03B | 9.80B | 9.51B | 9.25B |
| Cash, Cash Equivalents and Short-Term Investments | 1.01B | 1.42B | 2.04B | 1.87B | 2.26B | 1.86B |
| Total Debt | 2.73B | 2.25B | 2.42B | 1.56B | 1.30B | 1.09B |
| Total Liabilities | 4.31B | 3.88B | 4.28B | 4.23B | 4.02B | 4.10B |
| Stockholders Equity | 6.13B | 5.72B | 5.69B | 5.65B | 5.54B | 5.17B |
Cash Flow | ||||||
| Free Cash Flow | -168.74M | -86.32M | -459.31M | -1.06B | 514.93M | 623.59M |
| Operating Cash Flow | 92.45M | 299.37M | 224.71M | -357.54M | 1.07B | 1.13B |
| Investing Cash Flow | -770.46M | -899.16M | -740.92M | -723.98M | -606.57M | -402.58M |
| Financing Cash Flow | -325.59M | -273.59M | 682.45M | 664.11M | -34.09M | -494.87M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | HK$57.01B | 12.60 | 24.70% | 3.34% | 2.03% | 1.43% | |
66 Neutral | HK$25.92B | 19.48 | 18.11% | 4.83% | 23.90% | 10.72% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
59 Neutral | HK$3.75B | 12.85 | 4.53% | 2.83% | 0.52% | 99.51% | |
58 Neutral | HK$6.70B | 28.91 | 7.63% | 2.21% | -3.39% | 91.63% | |
56 Neutral | HK$58.71B | -180.14 | -0.74% | 3.65% | -7.36% | -107.25% | |
55 Neutral | HK$36.50B | 12.54 | 10.48% | 6.98% | -0.64% | -24.62% |
Ausnutria Dairy Corporation Ltd announced a clarification regarding its Probiotics Supply Framework Agreement, specifying the annual transaction caps for the financial years ending in 2025, 2026, and 2027. The caps are set at RMB10 million, RMB40 million, and RMB65 million, respectively, indicating a significant increase over the period, which may impact the company’s market positioning and operations.
Ausnutria Dairy Corporation Ltd. has entered into a Probiotics Supply Framework Agreement with Yili Industrial, a controlling shareholder, to supply probiotics and related products until December 2027. This agreement, classified as a continuing connected transaction under Hong Kong’s Listing Rules, does not require independent shareholders’ approval but is subject to reporting and annual review requirements, indicating a strategic partnership that could enhance Ausnutria’s market positioning and operational scope.